Cargando…
PCSK9 inhibition in patients with acute stroke and symptomatic intracranial atherosclerosis: protocol for a prospective, randomised, open-label, blinded end-point trial with vessel-wall MR imaging
INTRODUCTION: Dual antiplatelet therapy and high-intensity statins are the mainstay treatment in patients with acute stage, symptomatic intracranial atherosclerotic stenosis (ICAS). Alirocumab is a monoclonal antibody that can inhibit proprotein convertase subtilisin–kexin type 9 and effectively low...
Autores principales: | Huang, Yen-Chu, Chang, Chia-Hao, Tsai, Yuan-Hsiung, Weng, Hsu-Huei, Lin, Leng-Chieh, Lee, Jiann-Der |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058777/ https://www.ncbi.nlm.nih.gov/pubmed/35487727 http://dx.doi.org/10.1136/bmjopen-2021-060068 |
Ejemplares similares
-
MRA-free intracranial vessel localization on MR vessel wall images
por: Fan, Weijia, et al.
Publicado: (2022) -
Risk Factors for Asymptomatic and Symptomatic Intracranial Atherosclerosis Determined by Magnetic Resonance Vessel Wall Imaging in Chinese Population: A Case–Control Study
por: Han, Yongjun, et al.
Publicado: (2022) -
Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall
por: Ugovšek, Sabina, et al.
Publicado: (2022) -
Intracranial vessel wall lesions on 7T MRI and MRI features of cerebral small vessel disease: The SMART-MR study
por: Zwartbol, Maarten HT, et al.
Publicado: (2020) -
Factors for Enhancement of Intracranial Atherosclerosis in High Resolution Vessel Wall MRI in Ischemic Stroke Patients
por: Woo, Na-Eun, et al.
Publicado: (2020)